首页|2023年美国预防临床服务指南工作组《成年人焦虑障碍筛查推荐声明》解读

2023年美国预防临床服务指南工作组《成年人焦虑障碍筛查推荐声明》解读

Interpretation of Screening for Anxiety Disorders in Adults U.S.Preventive Services Task Force Recommendation Statement

扫码查看
焦虑障碍是最为常见的精神疾病,常在初级保健机构中被忽视,延误初始治疗的时间,严重影响患者的社会功能和生活质量.2023年美国预防临床服务指南工作组在JAMA上发表了《成年人焦虑障碍筛查推荐声明》(简称USPSTF推荐),并发布了最新证据报告和系统评价结果,其认为应对成年人进行焦虑障碍筛查,包括孕产妇,但目前对老年人进行焦虑障碍筛查的风险与获益证据不充分,无法确定筛查的利弊.本文结合USPSTF推荐和国内外研究现状,从成年人焦虑障碍的国内外流行病学现状、危险因素、早期筛查工具及利弊、治疗、声明对全科指导价值等方面进行了概述.
Anxiety disorders are the most common mental illnesses and are often overlooked in primary care settings,with delays in initial treatment and significant impairment on patients'social function and quality of life.In 2023,the U.S.Preventive Services Task Force(USPSTF)published a recommendation statement on adult anxiety disorder screening in JAMA,along with the latest evidence report and systematic review results.The USPSTF suggests screening for anxiety in adults,including pregnant and postpartum women.However,current evidence on the risks and benefits of screening for anxiety in older adults is insufficient to determine the pros and cons of screening.This article combines the USPSTF statement with domestic and international research to provide an overview of several aspects:the current state of adult anxiety disorders domestically and internationally,a summary of the USPSTF recommendation statement,risk factors,early screening tools and their pros and cons,treatment,and the value of the statement for general practice guidance.

AnxietyScreeningAdultStatementU.S.Preventive Services Task Force

雷玉、曾欣、王婷婷、周诗盼、沈静、邹川

展开 >

611130 四川省成都市第五人民医院全科医学科

611137 四川省成都市,成都中医药大学医学与生命学院

焦虑 筛查 成年人 声明 美国预防临床服务指南工作组

2023年四川省科学技术项目四川省卫生健康委员会课题2022年成都市医学科研课题

2023YFS0027川干研2024-1082021062

2024

中国全科医学
中国医院协会

中国全科医学

CSTPCD北大核心
影响因子:2.04
ISSN:1007-9572
年,卷(期):2024.27(14)
  • 42